Table 3. Clinical characteristics of patients with cutaneous melanoma in the three cohorts.
Variables | Training cohort | Testing cohort | Combined cohort | |
---|---|---|---|---|
(n=113) | (n=112) | (n=225) | ||
Vital status, n(%) | Alive | 43(38.1) | 43(38.4) | 86(38.2) |
Dead | 70(61.9) | 69(61.6) | 139(61.8) | |
Age years, n(%) | >=60 | 41(36.3) | 53(47.3) | 94(41.8) |
<60 | 72(63.7) | 56(50.0) | 128(56.9) | |
NA | 0 | 3(2.7) | 3(1.3) | |
Gender, n(%) | Female | 42(37.2) | 42(37.5) | 84(37.3) |
Male | 71(62.8) | 70(62.5) | 141(62.7) | |
Stage, n(%) | Stage I/II | 46(40.7) | 47(42.0) | 93(41.3) |
Stage III/IV | 50(44.3) | 45(40.1) | 95(42.2) | |
NA | 17(15.0) | 20(17.9) | 37(16.5) |